BARCLAYS PLC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$31
-27.9%
7,185
-8.3%
0.00%
Q2 2023$437,832
+16216.7%
0.00%
Q3 2022$0
-100.0%
48
-99.2%
0.00%
Q1 2022$40,000
-94.1%
6,378
-93.3%
0.00%
Q4 2021$674,000
+501.8%
95,370
+494.0%
0.00%
Q3 2021$112,000
+154.5%
16,056
+209.6%
0.00%
Q2 2021$44,000
-74.7%
5,186
-83.8%
0.00%
Q1 2021$174,000
+159.7%
32,005
+104.2%
0.00%
Q4 2020$67,000
+28.8%
15,671
-10.2%
0.00%
Q3 2020$52,000
-48.0%
17,451
-45.7%
0.00%
Q2 2020$100,00032,142
+100343.8%
0.00%
Q3 2019$0
-100.0%
32
-100.0%
0.00%
Q2 2019$150,000
+212.5%
75,122
+562.3%
0.00%
Q1 2019$48,000
+1100.0%
11,342
+806.6%
0.00%
Q4 2018$4,000
-95.3%
1,251
-92.2%
0.00%
Q3 2018$85,000
+507.1%
16,110
+524.9%
0.00%
Q2 2018$14,000
-46.2%
2,578
-50.4%
0.00%
Q1 2018$26,000
+225.0%
5,201
+82.6%
0.00%
Q2 2016$8,000
+700.0%
2,848
+1527.4%
0.00%
Q3 2015$1,000
-66.7%
175
-72.7%
0.00%
Q2 2015$3,000640
+1388.4%
0.00%
Q3 2014$0
-100.0%
43
-99.8%
0.00%
Q2 2014$72,000
+176.9%
17,976
+176.3%
0.00%
Q1 2014$26,000
-33.3%
6,506
-33.0%
0.00%
Q4 2013$39,000
+680.0%
9,706
+723.9%
0.00%
Q3 2013$5,000
-92.1%
1,178
-91.2%
0.00%
Q2 2013$63,00013,3420.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders